NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-242-2011-0-US-06 Isolation Of Novel Broadly Neutralizing Monoclonal Antibodies Against HIV-1 Using Epitope-specific Glycoprotein Probes To Identify HIV-1 Specific B-cells US DIV 16/366,980 Abandoned
NHLBI E-207-2016-0-US-03 Method To Increase Carboxylic Acid Content On Fluorescent Nanodiamonds US National Stage 16/336,709 10995004 Issued PDF
NCI E-062-2019-3-JP-05 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide JP National Stage 2019-516536 Abandoned
NCI E-062-2019-3-US-08 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate US National Stage 16/336,724 Abandoned
NCI E-100-2018-0-PCT-02 ACTIVATORS OF TYPE II NKT CELLS AND METHODS OF USE THEREOF PCT PCT PCT/US2019/023890 Expired
NIAID E-297-2016-2-JP-05 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES JP National Stage 2019-537752 Issued
NCATS E-040-2015-0-US-07 Compounds For Niemann Pick C And Other Iysosomal Storage Disorders US CON 16/362,179 Abandoned
NCI E-042-2014-0-US-17 CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 US DIV 16/360,281 11236161 Issued PDF
NCI E-280-2016-0-EP-04 METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME EP National Stage 17784443.8 Pending
NCI E-062-2019-3-SG-07 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide SG National Stage 11201902532R Abandoned
NCI E-280-2016-0-US-05 METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME US National Stage 16/334,872 11976299 Issued PDF
NIAID E-297-2016-2-US-06 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES US National Stage 16/335,099 10808012 Issued PDF
NCI E-048-2010-0-US-06 AGONIST / ANTAGONIST COMPOSITIONS AND METHODS OF USE US DIV 16/359,931 Abandoned
NINR E-222-2018-0-PCT-02 Methods Of Detecting Nucleic Acids Using Three-dimensional Paper Microfluidic Devices PCT PCT PCT/US2019/023234 Expired
NCI E-258-2016-0-US-07 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR
CCR4 AND ITS USE 		US National Stage 16/334,724 11077178 Issued PDF
NCI E-264-2011-0-AU-09 Delivery Of Packaged RNA To Mammalian Cells AU DIV 2019201911 Pending
NIDA E-017-2018-0-PCT-02 BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME PCT PCT PCT/US2019/022701 Expired
NIDA E-017-2018-0-EP-03 BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME EP National Stage 19714936.2 Pending
NLM E-124-2017-1-EP-02 METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS EP National Stage 17764475.4 Pending
NEI E-058-2018-0-EP-06 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO
VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL
THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS 		EP National Stage 19714930.5 Pending
NEI E-058-2018-0-JP-07 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO
VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL
THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS 		JP National Stage 2020-549687 Pending
NEI E-058-2018-0-CA-05 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO
VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL
THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS 		CA National Stage 3094078 Pending
NEI E-058-2018-0-PCT-02 Using Machine Learning And/or Neural Networks To Validate Stem Cells And Their Derivatives (2-D Cells And 3-D Tissues) for Use In Cell Therapy And Tissue Engineered Products PCT PCT PCT/US2019/022611 Expired
NCI E-097-2018-0-PCT-02 ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES PCT PCT PCT/US2019/022309 Expired
NIAID E-251-2016-0-US-04 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE US National Stage 16/333,561 Abandoned
NCATS E-253-2017-0-CL-04 C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME CL National Stage 2317-2020 Issued
NCATS E-253-2017-0-PCT-02 C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME PCT PCT PCT/US2019/021434 Expired
NCI E-157-2017-0-PCT-02 METHODS OF PREPARING POPULATIONS OF CELLS AND RETROVIRAL REAGENTS FOR ADOPTIVE CELL IMMUNOTHERAPY PCT PCT PCT/US2019/020903 Expired
NHLBI E-218-2016-1-PCT-02 Immunogens, Compositions, And Methods For Treating Dyslipidemia PCT PCT PCT/US2019/020900 Expired
NCI E-081-2018-0-PCT-02 17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER PCT PCT PCT/US2019/020989 Expired
NINDS E-025-2018-1-PCT-01 Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof PCT PCT COMB PCT/US2019/20896 Expired
NIAID E-145-2011-0-US-14 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA US DIV 16/292,722 10869865 Issued PDF
NINDS E-309-2009-1-US-08 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US DIV 16/291,731 11324840 Issued PDF
NCI E-141-2008-0-US-34 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof US CON 16/291,561 11110150 Issued PDF
NEI E-091-2018-0-EP-04 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION EP National Stage 19711759.1 Issued
NEI E-091-2018-0-JP-05 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION JP National Stage 2020-545170 Issued
NCATS E-757-2013-2-US-06 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS US CON 16/289,994 10752581 Issued PDF
NEI E-091-2018-0-PCT-02 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION PCT PCT PCT/US2019/020341 Expired
NEI E-091-2018-0-DE-08 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION DE EP 19711759.1 Pending
NEI E-091-2018-0-FR-07 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION FR EP 19711759.1 Pending
NEI E-091-2018-0-GB-09 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION GB EP 19711759.1 Pending
NCATS E-117-2018-0-PCT-02 Discovery Of 2,6-Dimethoxy-4-(5-Phenyl-4-Thiophen-2-yl-1H-Imidazol-2-yl)-Phenol (DPTIP) A Small Molecule Inhibitor Of Neutral Phingomyelinase 2 (nSMase2) For The Treatment Of Neurodegenerative And Oncologic Diseases PCT PCT PCT/US2019/020254 Expired
NEI E-091-2018-0-CA-03 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION CA National Stage 3091810 Pending
NIDDK E-742-2013-0-CN-08 A3 Adenosine Receptor Agonists CN DIV 201910154562.4 Issued
NIAID E-228-2016-1-US-02 STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US National Stage 16/329,592 11338033 Issued PDF
NIAID E-099-2016-0-US-17 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/288,630 10946048 Issued PDF
NCI E-175-2016-0-KR-10 ANTI-KRAS-G12D T CELL RECEPTORS KR National Stage 10-2019-7005837 Issued
NINDS E-235-2014-1-US-04 BIOMARKERS FOR DIAGNOSIS AND MANAGEMENT OF NEURO-IMMUNOLOGICAL DISEASES US DIV 16/284,914 10877049 Issued PDF
NHLBI E-029-2018-0-PCT-02 FAST MICRO TOMOGRAPHY SCANNER AND METHODS THEREOF PCT PCT PCT/US2019/019386 Abandoned
NIAID E-168-2016-0-US-03 METHOD AND COMPOSITION FOR OPTICAL CLEARING OF TISSUES US National Stage 16/328,553 1148-05-02 Issued PDF